Brussels, 08/07/2009 (Agence Europe) - On Wednesday 8 July, the European Commissioner for Competition presented the Commission's final report on competition in the pharmaceutical sector. Neelie Kroes explained that market entry of generic drugs is delayed. Whilst repeating the need to encourage innovation, she deplored the decline in new medicines coming on to the market. The Commission intends to intensify its scrutiny of the pharmaceutical sector under EC antitrust law, including continued...